OBJECTIVES: Extraction of chronically implanted cardiac implantable electrophysiological devices leads can be difficult. Excimer laserassisted extraction with 40 Hz sheaths has shown good results in challenging cases. In 2012, a new 80 Hz high-frequency laser sheath became available that delivers twice as many pulses per second. Here, we report our clinical experience with the new GlideLight 80 Hz laser sheath.
INTRODUCTION
An increasing number of transvenous extraction procedures of implantable cardioverter-defibrillator (ICD) and pacemaker leads has been performed in recent years. With a growing number of ICD and pacemaker implantation due to expansion in indications for ICD and cardiac resynchronization therapy as well as an aging population with a need for cardiac implantable electrophysiological devices, there is an emerging number of leads that need to be extracted [1] [2] [3] [4] [5] [6] . Cases of lead extraction procedures in patients with multiple or old leads are increasing, which adds to the procedural complexity of lead extraction in these patients [7] . There is also an increasing number of leads implanted, which in turn leads to an increase in number and complexity of lead extractions. In recent years, various lead extraction methods and systems have been used and reported in the literature. Methods for interventional lead removal including manual traction, use of locking stylets, dilator sheaths, femoral snares or laser sheaths have been described [7] [8] [9] [10] . Especially in older leads with strong adhesions, either the use of mechanical devices or laser sheaths enable high procedural success rates [11] [12] [13] . However, extraction of chronically implanted leads remains a difficult procedure with associated morbidity and mortality [12, 14, 15] . In recent years, SLS II 40 Hz laser sheaths achieved good results for extraction of chronically implanted ICD and pacemaker leads [10] [11] [12] [13] . The GlideLight 80 Hz high frequency laser sheath became available in 2012. Those sheaths deliver twice as many pulses per second and allow for the same advancement rate at half the force. As mechanical force is a major cause of complications during lead extraction procedures, we investigated the safety and efficacy of the new 80 Hz high frequency laser sheaths.
MATERIALS AND METHODS
Between January 2012 and August 2016, 151 patients with a pacemaker or ICD underwent laser lead extraction with 80 Hz high-frequency laser sheaths in our hospital. The patients were referred from external hospitals or from our electrophysiological outpatient clinic.
Lead extraction indications
Indications for lead extraction included systemic infection (sepsis and lead endocarditis) in 23.2% (n = 35) of patients, local infection in 48.3% (n = 73) of patients, lead dysfunction in 21.2% (n = 32) of patients, system upgrade in 3.3% (n = 5) of patients, tricuspid regurgitation in 2.0% (n = 3) of patients, and other indications in 2.0% (n = 3) of patients. All cases were discussed in an interdisciplinary heart team, including a cardiothoracic surgeon and an electrophysiologist.
Lead extraction and reimplantation technique
All procedures were performed by fluoroscopic guidance in a hybrid operating room under general anaesthesia. Continuous arterial blood pressure monitoring was performed. Threedimensional transoesophageal echocardiography was used to monitor the procedure. All patients were prepared for emergent sternotomy with cardiopulmonary bypass circuit standby.
Leads were dissected from the surrounding tissue and the sleeves were removed. Lead locking devices (LLD) were placed. Laser lead extraction was conducted using GlideLight 80 Hz laser sheaths (Spectranetics Corporation, Colorado Springs, CO, USA). Sheath sizes included 14 or 16 French sheaths. Laser lead extractions were performed with a single sheath technique, without outer sheaths.
Device reimplantation was performed as a one-step procedure from the contralateral side in patients without systemic infection parameters and with negative blood cultures. All patients received antibiotic prophylaxis for reimplantation. In patients with elevated infection parameters or positive blood cultures, a two-step reimplantation approach was conducted. In patients with pacemaker dependency for temporary pacing, a new activefixation right ventricle pacing lead was inserted at the ipsilateral side, subcutaneously tunnelled and connected to an externalized pacemaker device, as previously described by Pecha et al. [16] .
Definitions
Laser lead extraction was defined as the removal of leads using an Excimer laser sheath. Laser treatment time was defined as the time from beginning till the end of laser use.
Outcomes were determined according to the 2009 Heart Rhythm Society Expert Consensus article on transvenous lead extraction [14] .
Data
Data were collected into a computerized database at the time of the procedure and retrospectively analysed. The database includes patients' characteristics, indications for lead extraction, ICD lead age, defibrillation coils and fixation mode, as well as the extraction procedure information: laser treatment time, failure and complications. Files of patients having complications or failures were completely reviewed for more details. Data on 30-day mortality were also obtained.
Statistical analysis
Categorical variables are displayed as frequencies, and percentages were compared using the Fisher's exact test. Continuous values are expressed as mean ± standard deviation. All reported P-values are two-tailed, and P < 0.05 was considered significant. We used SPSS 21.0 (SPSS, Inc., Chicago, IL, USA) for statistical analysis.
RESULTS

Patients
The mean patient's age was 66.2 ± 14.4 years, 73.5% were male. Forty patients had a severely reduced left ventricular ejection fraction (<30%), while 39 patients (25.8%) had a history of a cardiac surgical procedure. Patient characteristics are shown in Table 1 .
Leads
A total of 292 leads were treated, including 91 (31.2%) atrial, 159 (54.4%) ventricular and 42 (14.4%) coronary sinus leads. Thirtythree single-and 47 dual-coil leads were extracted. Lead tip fixation was active in 201 leads (68.8%) and passive in 91 leads (31.2%). A total of 205 (70.2%) leads were implanted from the left side whereas 87 (29.8%) were implanted from the right side. Lead demographics are displayed in Table 2 .
Success and complication rates
Clinical success was achieved in 150/151 (99.3%) of the cases, while complete procedural success was observed 146/151 patients (96.7%). A failure of extraction was seen in 2 (1.3%) patients. Two-hundred and eighty-five of 292 (97.6) leads were completely extracted, whereas partial removal was observed in 4 leads (1.4%). Complete failure of lead extraction was seen in 3 (1.0%) leads. Partial removal occurred in 2 patients with Starfix LV activefixation leads, in each case a lead fragment <4 cm could not be removed. Additionally, in an 80-year old male patient in whom two active-fixation ICD leads ([right atrium and right ventricle] dual-coil lead) which had been implanted for 131 months could not be completely extracted due to lead breakage. Complete failure of extraction occurred in a 30-year old female patient with two implanted active-fixation pacemaker leads (right atrium, right ventricle lead), and the age of the leads was 140 months [19] . Furthermore, a Starfix lead with the age of 30.1 months could not be removed in another female patient. The patient was treated with systemic antibiotic therapy for 14 days. The infection parameters were normalized and there was no further evidence for infection. Outcome and complications are detailed in Table 3 . Mean laser treatment time was 67.5 ± 71.3 s, mean laser pulses delivered were 5130 ± 6592.
No intraprocedural death occurred during the study. The overall complication rate was 2.0%. Two major (1.3%) and one minor (0.7%) complications occurred in our group of patients. The major complications included one lateral perforation of the superior vena cava. A 75-year old male patient with two activefixation pacemaker leads, implanted for 154 months after an emergent sternotomy, was successfully sutured without cardiopulmonary bypass and further complications. The other major complication was a laceration of the right atrial appendage, which was successfully sutured after sternotomy, without cardiopulmonary bypass. Furthermore, one pocket haematoma, that had to be surgically revised, was the only minor complication in this series. We did not see a significant worsening of tricuspid function in any of the patients after lead extraction. Furthermore, no embolization of debris or clinically relevant pulmonary embolism was seen. However, especially in patients with lead vegetations, the occurrence of a microembolism into the lungs cannot be excluded.
DISCUSSION
We report the largest series of patients treated with the GlideLight 80 Hz laser sheath for extraction of chronically implanted ICD and pacemaker leads. In this group of 151 patients, we observed a high complete procedural success rate of 96.7% combined with a low rate of major (1.3%) and minor (0.7%) complications. Furthermore, no extraction related mortality was seen.
With rising numbers of ICD and pacemaker implantations, the number of devices that need extraction is simultaneously increasing. However, due to the above-mentioned conditions, lead extraction by manual traction, with lead locking devices or with means of dilator sheaths, is often not sufficient for a complete lead extraction. Therefore, either mechanical or laser-assisted lead extraction techniques allow for higher procedural success rates. The Excimer laser energy ablates a ring of tissue in contact with the tip of the laser catheter at a depth of 50 microns. This small penetration depth allows for precise debulking of the binding sites and minimizes the risk of surrounding vessel injury.
The earlier 40 Hz laser sheaths have shown excellent results in prospective as well as retrospective studies. Procedural success rates ranging between 90.0 and 96.5% have been published. Furthermore, a low number of major and minor complication rates have been described. In 2012, the GlideLight 80 Hz high frequency laser sheaths were introduced. Those sheaths deliver twice as many pulses per second compared to the SLS II 40 Hz laser sheaths, thereby allowing for the same advancement rate at half the force. Furthermore, 80 Hz sheaths are admitting a 62.0% more effective advancement through binding sites using the same force. High mechanical force is one of the major issues contributing to extraction related complications including vascular injury, dislodgement of adjacent leads, or lead breakage and damage [12, 17, 18] . Therefore, the GlideLight sheaths might help to minimize complication rates during lead extraction by reducing the necessity for mechanical force.
To date, the published experience with the 80 Hz high frequency laser sheaths is quite limited. Apart from our own published initial experience of 38 patients treated with GlideLight laser sheaths [19] , there is only one additional study by Tanawuttiwat et al. [20] . This study, included 112 patients treated with high frequency laser sheaths with a procedural success rate of 100% was seen. Furthermore, they observed a mortality rate of 0.9% and a minor complication rate of 3.6%. The results of the 80 Hz group were compared to 315 patients treated with 40 Hz laser sheaths. They did not find any statistical significant differences regarding procedural success rate, as well as minor and major complication rates. The authors conclude that this might be related to the relatively low number of complications and high rate of procedural success in both groups. Tanawuttiwat et al. observed significantly shorter laser treatment times in the 80 Hz high frequency laser group. Similar results were seen for the number of pulses delivered during extraction procedure. These findings from Tanawuttiwat et al. are in line with our observations. We also found a high complete procedural success rate of 96.7%. Our previously published lead extraction experience with the SLS II 40 Hz laser sheaths showed a complete lead removal rate of 93.5% in 504 treated leads [19] . Total and partial failure of extraction occurred in 2.78 and 3.77% of patients, respectively [19] . When comparing these results to those with 80 Hz laser sheaths, where we achieved complete removal of 285 of 292 leads (97.6%), there is a significantly higher success rate with the high frequency laser sheaths (P = 0.018). However, this observation has to be taken with caution, as it is difficult to compare our actual results to a historic patient group, treated between 1999 and 2012. Differences in procedural settings like use of a hybrid operating room, 3D TEE and intraoperative fluoroscopy that have been used since 2012, might have influenced the higher success rate in our recent cohort of patients treated with 80 Hz laser sheaths. In other previous published prospective as well as retrospective studies using 40 Hz laser sheets, procedural success rates ranged between 90.0 and 96.5% [11, 12, 15, 21] . The major complication rate (1.3%) of this study is comparable to the data by Tanawuttiwat et al. [20] and to previous published results for SLS II 40 Hz sheaths ranging between 1.9 and 2.5% [11, 12, 15, 21] . Regarding the low percentage of complication rates in low-as well as high-frequency laser sheaths, it is difficult to distinguish any statistically significant differences between the two types of sheaths.
In our series with the GlideLight high frequency laser sheaths, no intraoperative or extraction related mortality was observed. In studies using GlideLight 40 Hz laser sheaths, mortality rates ranged from 0.7 to 1.9%. The major complications and risk for mortality in lead extraction procedures illustrate the necessity for a safety network, including invasive arterial pressure monitoring, transoesophageal echocardiography, a cardiopulmonary bypass circuit standby, and having the patient prepared for emergent sternotomy.
CONCLUSION
We have shown the efficacy and safety of the new 80 Hz high frequency laser sheaths in a large patient cohort. Low complication rates combined with a high number of complete procedural success makes the 80 Hz laser sheaths a useful tool for extraction of chronically implanted ICD and pacemaker leads.
